Market Overview:
The global tramadol tablets market is expected to grow at a CAGR of 3.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and growing demand for pain relief medications. By type, the 50 mg tramadol tablets segment is expected to account for the largest share of the global market in 2018. By application, the hospital segment is expected to account for the largest share of the global market in 2018.
Product Definition:
Tramadol tablets are opioid analgesics which are used to treat moderate to severe pain. They work by binding to the opioid receptors in the brain and spinal cord, which reduces the perception of pain.
50 mg,100 count:
50 mg,100 count, it's usage and growth factor in Tramadol Tablets market is expected to grow at a significant rate over the forecast period. The 50 mg/100 count tablets are used for the treatment of chronic pain due to cancer or arthritis. It works by decreasing the activity in certain brain areas that respond to pain.
50 mg,500 count:
50 mg,500 count is used in the manufacturing of Tramadol Tablets. It is a white to off-white crystalline powder and has a mild odor. The drug substance contains 50 mg of codeine phosphate and 500 mg of paracetamol, which is equivalent to that of 100mg codeine phosphate and 1000 mg paracetamol tablets sold commercially.
The product was developed by Dr. Reddy's Laboratories Ltd.
Application Insights:
On the basis of application, the global tramadol tablets market is segmented into hospital, specialty clinic and diagnostic center. Hospital was estimated as largest revenue generating segment in 2017 owing to high usage of tramadol for pain management and other medical conditions. In addition, presence of major players with a strong distribution network across the globe further supports its dominance in this segment.
Tramadol is an opioid analgesic drug that works by binding to receptors located throughout the brain stem which reduces pain perception. It has been approved by U.S FDA under schedule II category for use as an analgesic medication with moderate risk for abuse and dependence (2). The demand for oral tablets containing 100 mg or 500 mg dose has been witnessed particularly in Europe where OTC availability is allowed but not within healthcare settings (3). However, it remains a schedule II drug under U.
Regional Analysis:
Europe dominated the global tramadol tablets market in 2017 owing to the presence of a large number of tramadol consumers. The region is expected to maintain its dominance over the forecast period due to various factors such as rising geriatric population, increasing prevalence of pain and depression, and growing awareness about drug abuse. Moreover, government initiatives for controlling substance abuse are also expected to boost regional growth. For instance, in May 2018 Germany’s Federal Institute for Drugs and Medical Devices (Bundesinstitut f¼r Arzneimittel und Medizinische Wissenschaften) released new guidelines that will make it mandatory for all prescription drugs with potential opioid-like effects to be registered before marketing approval by 2020.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for tramadol tablets as they are prescribed for treating pain in elderly patients.
- Rising prevalence of chronic pain: The prevalence of chronic pain is on the rise due to various factors such as lifestyle changes, obesity, and stress. This is expected to boost the demand for tramadol tablets as they are effective in relieving chronic pain.
- Growing awareness about benefits of tramadol tablets: There has been a growing awareness about the benefits of tramadol tablets among healthcare professionals and consumers alike. This is likely to fuel the growth of this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Tramadol Tablets Market Research Report
By Type
50 mg,100 count, 50 mg,500 count, 50 mg,1000 count
By Application
Hospital, Specialty Clinic, Diagnostic Center
By Companies
Virtus, Amneal, Major Pharmaceuticals, Mylan, Sun Pharma, Zydus, CSPC Group, Heilongjiang Duoduo Pharm, Neptunuds, Beijing Huasu Pharmaceutical, Guangzhou Bosailuo, Zhengzhou Kaili Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Tramadol Tablets Market Report Segments:
The global Tramadol Tablets market is segmented on the basis of:
Types
50 mg,100 count, 50 mg,500 count, 50 mg,1000 count
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Specialty Clinic, Diagnostic Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Virtus
- Amneal
- Major Pharmaceuticals
- Mylan
- Sun Pharma
- Zydus
- CSPC Group
- Heilongjiang Duoduo Pharm
- Neptunuds
- Beijing Huasu Pharmaceutical
- Guangzhou Bosailuo
- Zhengzhou Kaili Pharmaceutical
Highlights of The Tramadol Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 50 mg,100 count
- 50 mg,500 count
- 50 mg,1000 count
- By Application:
- Hospital
- Specialty Clinic
- Diagnostic Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Tramadol Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Tramadol Tablets are a medication used to treat pain. Tramadol Tablets are also known as Ultram, and they come in tablet form.
Some of the major players in the tramadol tablets market are Virtus, Amneal, Major Pharmaceuticals, Mylan, Sun Pharma, Zydus, CSPC Group, Heilongjiang Duoduo Pharm, Neptunuds, Beijing Huasu Pharmaceutical, Guangzhou Bosailuo, Zhengzhou Kaili Pharmaceutical.
The tramadol tablets market is expected to grow at a compound annual growth rate of 3.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Tramadol Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Tramadol Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Tramadol Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Tramadol Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Tramadol Tablets Market Size & Forecast, 2020-2028
4.5.1 Tramadol Tablets Market Size and Y-o-Y Growth
4.5.2 Tramadol Tablets Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 50 mg
5.2.2 100 count
5.2.3 50 mg
5.2.4 500 count
5.2.5 50 mg
5.2.6 1000 count
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Specialty Clinic
6.2.3 Diagnostic Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Tramadol Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Tramadol Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 50 mg
9.6.2 100 count
9.6.3 50 mg
9.6.4 500 count
9.6.5 50 mg
9.6.6 1000 count
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Specialty Clinic
9.10.3 Diagnostic Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 50 mg
10.6.2 100 count
10.6.3 50 mg
10.6.4 500 count
10.6.5 50 mg
10.6.6 1000 count
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Specialty Clinic
10.10.3 Diagnostic Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 50 mg
11.6.2 100 count
11.6.3 50 mg
11.6.4 500 count
11.6.5 50 mg
11.6.6 1000 count
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Specialty Clinic
11.10.3 Diagnostic Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 50 mg
12.6.2 100 count
12.6.3 50 mg
12.6.4 500 count
12.6.5 50 mg
12.6.6 1000 count
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Specialty Clinic
12.10.3 Diagnostic Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 50 mg
13.6.2 100 count
13.6.3 50 mg
13.6.4 500 count
13.6.5 50 mg
13.6.6 1000 count
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Specialty Clinic
13.10.3 Diagnostic Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Tramadol Tablets Market: Competitive Dashboard
14.2 Global Tramadol Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Virtus
14.3.2 Amneal
14.3.3 Major Pharmaceuticals
14.3.4 Mylan
14.3.5 Sun Pharma
14.3.6 Zydus
14.3.7 CSPC Group
14.3.8 Heilongjiang Duoduo Pharm
14.3.9 Neptunuds
14.3.10 Beijing Huasu Pharmaceutical
14.3.11 Guangzhou Bosailuo
14.3.12 Zhengzhou Kaili Pharmaceutical
